Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.

G. Giaccone; E.F. Smit; M. de Jonge; E Dansin; E Briasoulis; A. Ardizzoni; JY Douillard; D Spaeth; D Lacombe; B Baron; P Bachmann; P Fumoleau

doi:10.1016/j.ejca.2003.10.027

Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.

G. Giaccone
, E.F. Smit
, M. de Jonge
, E Dansin
, E Briasoulis
, A. Ardizzoni
, JY Douillard
, D Spaeth
, D Lacombe
, B Baron
, P Bachmann
, P Fumoleau

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	667-72
Journal	European Journal of Cancer
Volume	40
Issue number	5
DOIs	https://doi.org/10.1016/j.ejca.2003.10.027
Publication status	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2003.10.027

Cite this

Giaccone, G., Smit, E. F., de Jonge, M., Dansin, E., Briasoulis, E., Ardizzoni, A., Douillard, JY., Spaeth, D., Lacombe, D., Baron, B., Bachmann, P., & Fumoleau, P. (2004). Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group. European Journal of Cancer, 40(5), 667-72. https://doi.org/10.1016/j.ejca.2003.10.027

@article{37bbcc18c9f54aeab23780717840e221,

title = "Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.",

author = "G. Giaccone and E.F. Smit and \{de Jonge\}, M. and E Dansin and E Briasoulis and A. Ardizzoni and JY Douillard and D Spaeth and D Lacombe and B Baron and P Bachmann and P Fumoleau",

year = "2004",

doi = "10.1016/j.ejca.2003.10.027",

language = "English",

volume = "40",

pages = "667--72",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "5",

}

Giaccone, G, Smit, EF, de Jonge, M, Dansin, E, Briasoulis, E, Ardizzoni, A, Douillard, JY, Spaeth, D, Lacombe, D, Baron, B, Bachmann, P & Fumoleau, P 2004, 'Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.', European Journal of Cancer, vol. 40, no. 5, pp. 667-72. https://doi.org/10.1016/j.ejca.2003.10.027

TY - JOUR

T1 - Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.

AU - Giaccone, G.

AU - Smit, E.F.

AU - de Jonge, M.

AU - Dansin, E

AU - Briasoulis, E

AU - Ardizzoni, A.

AU - Douillard, JY

AU - Spaeth, D

AU - Lacombe, D

AU - Baron, B

AU - Bachmann, P

AU - Fumoleau, P

PY - 2004

Y1 - 2004

U2 - 10.1016/j.ejca.2003.10.027

DO - 10.1016/j.ejca.2003.10.027

M3 - Article

SN - 0959-8049

VL - 40

SP - 667

EP - 672

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 5

ER -